Search

Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease

Journal: Current Alzheimer Research
Volume: 14 Issue: 12 Year: 2017 Page: 1305-1317
Author(s): A. Arena,A. M. Iyer,I. Milenkovic,G. G. Kovacs,I. Ferrer,M. Perluigi,E. Aronica

Mouse Models of Down Syndrome and Alzheimer’s Disease: Similarities and Differences

Ebook: Recent Advances in Alzheimer Research
Volume: 1 Year: 2015
Author(s): Noemí Rueda,Carmen Martínez-Cué
Doi: 10.2174/9781681081380115010013

Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy

Journal: Current Alzheimer Research
Volume: 13 Issue: 1 Year: 2016 Page: 68-83
Author(s): Cristy Phillips,Atoossa Fahimi,Devsmita Das,Fatemeh S. Mojabi,Ravikumar Ponnusamy,Ahmad Salehi

Role of APP in the Pathophysiology of Down Syndrome and Alzheimer’s Disease

Ebook: Recent Advances in Alzheimer Research
Volume: 1 Year: 2015
Author(s): Kumar Sambamurti,Miguel A. Pappolla,Debomoy K. Lahiri,Nigel H. Greig,Panneerselvam Chinnakannu,Ann-Charlotte Granholm,Vasudevaraju Padmaraju
Doi: 10.2174/9781681081380115010014

A Dual Mechanism Linking NGF/proNGF Imbalance and Early Inflammation to Alzheimers Disease Neurodegeneration in the AD11 Anti-NGF Mouse Model

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 5 Year: 2011 Page: 635-647
Author(s): S. Capsoni, R. Brandi, I. Arisi, M. DOnofrio, A. Cattaneo

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2411-2430
Author(s): Mak Adam Daulatzai

Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 10 Issue: 2 Year: 2015 Page: 122-141
Author(s): Andrea Chicca, Chiara Arena, Clementina Manera